Kirk Herbstreit Details 2022 Pulmonary Embolism

The sports analyst revealed he was diagnosed with blood clots in his lungs in April 2022.

Updated on Oct. 15, 2026 in Asthma

Bold flat-color editorial illustration in navy and cream with a deep red accent, showing an abstract arched structure representing cardiovascular health. — Sports analyst Kirk Herbstreit revealed a 2022 diagnosis of pulmonary embolism, a serious cardiovascular condition he manages with daily blood thinners. AI Illustration. Upload story photo >

Kirk Herbstreit disclosed in October 2026 that he was diagnosed with a pulmonary embolism in April 2022 after blood clots traveled from his leg to his lungs. The health scare forced the analyst to miss ESPN NFL Draft coverage at the time.

Why it matters

The diagnosis highlights the risks of pulmonary embolism, a serious medical condition that impacts the cardiovascular system. It also demonstrates how such events can impact professional commitments for public figures.

A pulmonary embolism is a serious condition that causes approximately 100,000 deaths annually in the United States. The condition has an annual prevalence rate of roughly 1 in 1,000 individuals.

The players

Kirk Herbstreit

He is a prominent sports analyst and former quarterback for the Ohio State Buckeyes.

The details

Doctors discovered the blood clots following a heart scan conducted in April 2022. Herbstreit has been required to take the blood thinner Xarelto daily since the diagnosis to manage his condition.

April 2022: Kirk Herbstreit received a pulmonary embolism diagnosis.
October 2026: Herbstreit disclosed his medical history during a show appearance.

Health Landscape

This disclosure follows a pattern of public figures managing significant cardiovascular conditions through long-term medical intervention. It reflects the broader evolution of patient care where chronic management is standard for preventing recurring thromboembolic events.

Individuals diagnosed with a pulmonary embolism typically require strict adherence to prescribed blood-thinning medications for life. Patients should consult their doctors regarding daily health routines and any signs of recurring clotting.

The takeaway

Pulmonary embolism is a life-threatening event that requires immediate and sustained medical treatment. Patients should maintain consistent communication with their healthcare providers regarding the long-term management of anticoagulant therapies.